Clinical Trial Update: Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study) [Phase 3]

View source ↗

Summary

Phase 3 EPSILON study evaluating early Parkinson's disease patients treated with L-DOPA/DDCI plus opicapone has completed. The report notes completion but does …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Carbidopa (Carbidopa)
• OpiCapone
• levodopa (levodopa)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson | Phase 3 | Status: COMPLETED